Randall Kaye, CMO at Longboard Pharmaceuticals, Inc. (LBPH), sold 26,032 shares at $34.04 ($817K) on 2024-09-16, disclosed to the SEC on 2024-09-16.
Scheduled sale ($817k) by CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.89 | 9,366 | $289K | 35.4% |
| 2 | $30.89 | 9,366 | $289K | 35.4% |
| 3 | $31.81 | 4,200 | $134K | 16.4% |
| 4 | $33.12 | 1,200 | $40K | 4.9% |
| 5 | $34.04 | 1,900 | $65K | 7.9% |
| Total | $31.37 avg | 26,032 |
| $817K |
| 100% |
| Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |
| AVNR | SELL | 2011-09-13 | $275K | — | Filing → |